Inozyme Pharma presents positive interim data on INZ-701 at CHOP Cardiology 2025
Inozyme Pharma Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases affecting bone health and blood vessels, has presented promising ... Read More